Pure Global

Outcomes of a Palliative Care Intervention to Improve Kidney Therapy Decision-Making for Older People With Advanced Chronic Kidney Disease (CKD) - Trial NCT06410144

Access comprehensive clinical trial information for NCT06410144 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Rochester and is currently Not yet recruiting. The study focuses on Chronic Kidney Diseases. Target enrollment is 326 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06410144
Not yet recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06410144
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Outcomes of a Palliative Care Intervention to Improve Kidney Therapy Decision-Making for Older People With Advanced Chronic Kidney Disease (CKD)

Study Focus

Chronic Kidney Diseases

CKD-EDU

Interventional

behavioral

Sponsor & Location

University of Rochester

Rochester, United States of America

Timeline & Enrollment

N/A

May 01, 2024

May 01, 2029

326 participants

Primary Outcome

Changes in Kidney Therapy Decision-Making Process using the Decisional Conflict Scale at 4-6 weeks

Summary

The investigators are conducting a study to see if an educational program called Chronic
 Kidney Disease-Education (CKD-EDU) can help make better kidney therapy decisions and improve
 the well-being of older adults. Investigators are also investigating if this program can
 reduce the number of hospital or emergency room visits in the first 6 months of the study, as
 well as potentially improve end-of-life care for older adults.
 
 Half of the participants will receive the CKD-EDU intervention, while the other half will
 continue with their usual nephrology care. Investigators will compare the two groups to see
 if participants who received the intervention feel better prepared about their kidney therapy
 decisions, experience improved end-of-life care, and have fewer emergency room visits,
 hospital admissions,
 
 Participants in the intervention group will get information about kidney disease treatment
 and meet with a palliative care specialist who's an expert in decision-making.

ICD-10 Classifications

Chronic kidney disease
Chronic kidney disease, unspecified
Chronic kidney disease, stage 1
Chronic kidney disease, stage 4
Chronic kidney disease, stage 2

Data Source

ClinicalTrials.gov

NCT06410144

Non-Device Trial